Serum TBA quintiles | P | |||||
---|---|---|---|---|---|---|
Q1 (n = 31,267) | Q2 (n = 30,136) | Q3 (n = 31,298) | Q4 (n = 29,245) | Q5 (n = 30,390) | ||
Clinical characteristics | ||||||
Age, years | 44 (12) | 45 (13) | 45 (13) | 46 (14) | 48 (15) | <.001 |
Male percentage, % (n) | 42.5% (13,284) | 52.0% (15,679) | 55.7% (17,428) | 58.6% (17,129) | 62.6% (19,013) | <.001 |
BMI, kg/m2 | 23.7 (3.3) | 24.0 (3.3) | 24.1 (3.4) | 24.2 (3.4) | 24.3 (3.4) | <.001 |
Systolic pressure, mm Hg | 117 (17) | 119 (17) | 120 (17) | 121 (17) | 123 (18) | <.001 |
Diastolic pressure, mm Hg | 74 (11) | 75 (11) | 76 (11) | 76 (11) | 77 (11) | <.001 |
NALFD, % (n) | 20.8% (6512) | 26.0% (7840) | 28.8% (9012) | 30.4% (8895) | 31.3% (9512) | <.001 |
Hypertension, % (n) | 14.7% (4581) | 17.6% (5309) | 19.3% (6028) | 21.9% (6403) | 24.5% (7446) | <.001 |
T2D, % (n) | 2.0% (630) | 3.1% (931) | 3.7% (1161) | 4.6% (1358) | 5.1% (1543) | <.001 |
CAD, % (n) | 0.9% (269) | 0.9% (282) | 1.2% (387) | 1.4% (407) | 1.9% (575) | <.001 |
Biochemical parameters | <.001 | |||||
AST, U/L | 20 (7) | 21 (9) | 22 (9) | 23 (10) | 26 (32) | <.001 |
ALT, U/L | 22 (14) | 25 (18) | 26 (20) | 27 (22) | 32 (44) | <.001 |
BUN, mmol/L | 4.8 (1.4) | 4.9 (1.4) | 5.1 (1.5) | 5.1 (1.5) | 5.1 (1.5) | <.001 |
Cr, μmol/L | 64.6 (21.7) | 66.7 (21.5) | 67.9 (26.6) | 68.3 (21.7) | 69.2 (20.5) | <.001 |
UA, μmol/L | 299.1 (80.3) | 310.4 (82.6) | 314.7 (83.2) | 317.3 (83.8) | 320.6 (84.2) | <.001 |
FBG, mmol/L | 4.90 (1.01) | 4.98 (1.18) | 5.04 (1.31) | 5.11 (1.41) | 5.16 (1.49) | <.001 |
TC, mmol/L | 4.65 (0.91) | 4.66 (0.92) | 4.66 (0.92) | 4.67 (0.95) | 4.66 (0.97) | 0.103 |
HDLC, mmol/L | 1.35 (0.29) | 1.32 (0.29) | 1.30 (0.29) | 1.29 (0.30) | 1.28 (0.31) | <.001 |
LDLC, mmol/L | 2.70 (0.76) | 2.69 (0.77) | 2.68 (0.77) | 2.67 (0.78) | 2.62 (0.78) | <.001 |
RLP-C, mmol/L | 0.60 (0.47) | 0.65 (0.56) | 0.68 (0.60) | 0.71 (0.66) | 0.76 (0.74) | <.001 |
TG, mmol/L | 1.11 (0.80–1.61) | 1.21 (0.84–1.81) | 1.25 (0.87–1.90) | 1.30 (0.89–1.97) | 1.34 (0.92–2.06) | <.001 |